Back to
Royal Bank of Canada
MCRB
Showing 4 of 24 quarters
Position history for
Royal Bank of Canada's holdings in Seres Therapeutics, Inc.
As of its Q1 2025 13F, Royal Bank of Canada held 4,444 shares of MCRB (Seres Therapeutics), worth $3,000. Royal Bank of Canada's 13F filings listed MCRB from Q3 2019 to Q1 2025, 23 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
-132
Quarter-by-Quarter History